Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics

Rachna M Kumar1, Hitesh Kumar1, Tanvi Bhatt1

  • 1Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570015, India.

Insights

Fisetin, a natural compound, shows promise for cancer treatment due to its anticancer properties. However, poor bioavailability necessitates nanomedicine formulations for effective clinical use.

Area of Science:

  • Oncology
  • Pharmacology
  • Nanomedicine

Background:

  • Cancer is a leading global cause of mortality, characterized by cell invasion and metastasis.
  • Fisetin, a natural flavone, exhibits antioxidant, anti-inflammatory, antiangiogenic, and anticancer properties.
  • Fisetin inhibits tumor growth, invasiveness, and metastasis by hindering cancer cell multiplication and inducing apoptosis.

Purpose of the Study:

  • To review fisetin's potential as an anticancer therapeutic agent.
  • To discuss fisetin's pharmacological properties relevant to cancer treatment.
  • To explore nanomedicine formulation strategies for improving fisetin delivery.

Main Methods:

  • Literature review of fisetin's anticancer mechanisms and properties.
  • Analysis of fisetin's pharmacokinetic challenges, including poor bioavailability and hydrophobicity.
  • Exploration of nanomedicine approaches like liposomes and nanocochleates for fisetin formulation.

Main Results:

  • Fisetin demonstrates significant anticancer effects by inhibiting cancer cell proliferation and promoting apoptosis via caspase pathways.
  • Poor bioavailability and hydrophobicity limit fisetin's clinical application.
  • Nanomedicine strategies offer potential solutions to enhance fisetin delivery and efficacy.

Conclusions:

  • Fisetin is a promising natural compound for anticancer therapy.
  • Overcoming bioavailability limitations through nanomedicine is crucial for its clinical translation.
  • Further research into fisetin-loaded nanocarriers can optimize its therapeutic potential.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Role of Septins01:02

Role of Septins

Septins are the recently discovered fourth major protein component of the cytoskeleton, along with microfilaments, microtubules, and intermediate filaments. These proteins can associate with other cytoskeletal filaments and carry out varied roles or can be free-floating in the cytoplasm.
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
1.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K